James Thomas Toguri

596 total citations
21 papers, 454 citations indexed

About

James Thomas Toguri is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Ophthalmology. According to data from OpenAlex, James Thomas Toguri has authored 21 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Ophthalmology. Recurrent topics in James Thomas Toguri's work include Cannabis and Cannabinoid Research (12 papers), Sleep and Wakefulness Research (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). James Thomas Toguri is often cited by papers focused on Cannabis and Cannabinoid Research (12 papers), Sleep and Wakefulness Research (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). James Thomas Toguri collaborates with scholars based in Canada, United States and Saudi Arabia. James Thomas Toguri's co-authors include Michael E. Kelly, Anna-Maria Szczesniak, Christine Lehmann, Robert B. Laprairie, Juan Zhou, Eileen M. Denovan‐Wright, Elizabeth A. Cairns, Amina M. Bagher, Robin Urquhart and Sufia Islam and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and British Journal of Pharmacology.

In The Last Decade

James Thomas Toguri

20 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Thomas Toguri Canada 13 283 117 68 62 51 21 454
Simon N. Pettit United States 7 112 0.4× 30 0.3× 13 0.2× 81 1.3× 14 0.3× 8 317
Han Na Park United States 17 33 0.1× 95 0.8× 59 0.9× 302 4.9× 37 0.7× 43 813
Rachel Y. Gao United States 7 296 1.0× 65 0.6× 37 0.5× 119 1.9× 22 0.4× 12 482
Antonio Munafò Italy 11 74 0.3× 69 0.6× 12 0.2× 161 2.6× 9 0.2× 22 579
Ernst Agneter Austria 13 116 0.4× 190 1.6× 20 0.3× 202 3.3× 5 0.1× 18 483
Alan J. Tuchman United States 11 70 0.2× 78 0.7× 10 0.1× 52 0.8× 106 2.1× 22 447
Carlos Eduardo Silvado Brazil 16 24 0.1× 81 0.7× 55 0.8× 117 1.9× 9 0.2× 52 587
Kenneth Clark United States 7 32 0.1× 67 0.6× 20 0.3× 66 1.1× 30 0.6× 8 355
Andrew Winterborn Canada 14 54 0.2× 74 0.6× 10 0.1× 136 2.2× 10 0.2× 23 572
E Molina Italy 14 45 0.2× 180 1.5× 14 0.2× 139 2.2× 30 0.6× 39 485

Countries citing papers authored by James Thomas Toguri

Since Specialization
Citations

This map shows the geographic impact of James Thomas Toguri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Thomas Toguri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Thomas Toguri more than expected).

Fields of papers citing papers by James Thomas Toguri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Thomas Toguri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Thomas Toguri. The network helps show where James Thomas Toguri may publish in the future.

Co-authorship network of co-authors of James Thomas Toguri

This figure shows the co-authorship network connecting the top 25 collaborators of James Thomas Toguri. A scholar is included among the top collaborators of James Thomas Toguri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Thomas Toguri. James Thomas Toguri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
James, Helen, et al.. (2024). Pilot Study: Moving Towards a Scalable Intervention for Postgraduate Communication Skills Training. SHILAP Revista de lepidopterología. 5(1). 293–300.
2.
Toguri, James Thomas, et al.. (2020). Views of advanced cancer patients, families, and oncologists on initiating and engaging in advance care planning: a qualitative study. BMC Palliative Care. 19(1). 150–150. 21 indexed citations
3.
Bagher, Amina M., A. P. Young, Robert B. Laprairie, et al.. (2020). Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments. Journal of Neuroscience Research. 98(12). 2496–2509. 12 indexed citations
4.
5.
Szczesniak, Anna-Maria, James Thomas Toguri, Simon Gebremeskel, et al.. (2019). Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis. Molecules. 24(18). 3338–3338. 18 indexed citations
6.
7.
Murataeva, Natalia, Anna-Maria Szczesniak, Emma Leishman, et al.. (2018). Revisiting cannabinoid receptor 2 expression and function in murine retina. Neuropharmacology. 141. 21–31. 18 indexed citations
8.
Toguri, James Thomas, Emma Leishman, Anna-Maria Szczesniak, et al.. (2018). Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye. Prostaglandins & Other Lipid Mediators. 139. 54–62. 18 indexed citations
9.
Cairns, Elizabeth A., et al.. (2018). The Cannabinoids Δ 8 THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation. Cannabis and Cannabinoid Research. 3(1). 11–20. 83 indexed citations
10.
Islam, Sadia, et al.. (2017). Evaluation of iris functional capillary density in experimental local and systemic inflammation. Journal of Microscopy. 266(1). 55–59. 6 indexed citations
11.
Bagher, Amina M., Robert B. Laprairie, James Thomas Toguri, Michael E. Kelly, & Eileen M. Denovan‐Wright. (2017). Bidirectional allosteric interactions between cannabinoid receptor 1 (CB 1 ) and dopamine receptor 2 long (D 2L ) heterotetramers. European Journal of Pharmacology. 813. 66–83. 32 indexed citations
12.
13.
Mcilroy, Stuart, et al.. (2017). In vivo classification of inflammation in blood vessels with convolutional neural networks. 3022–3027. 2 indexed citations
14.
Szczesniak, Anna-Maria, James Thomas Toguri, Simon Gebremeskel, et al.. (2016). Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy. Neuropharmacology. 113(Pt B). 627–638. 27 indexed citations
15.
Toguri, James Thomas, et al.. (2016). Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain. Frontiers in Pharmacology. 7. 304–304. 18 indexed citations
16.
Cairns, Elizabeth A., et al.. (2015). Seeing over the horizon – targeting the endocannabinoid system for the treatment of ocular disease. Journal of Basic and Clinical Physiology and Pharmacology. 27(3). 253–265. 22 indexed citations
17.
Islam, Sufia, Juan Zhou, Maria del Carmen Parquet, et al.. (2015). Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis. Journal of Surgical Research. 200(1). 266–273. 38 indexed citations
18.
Toguri, James Thomas, et al.. (2015). Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation. Clinical Hemorheology and Microcirculation. 61(2). 237–249. 30 indexed citations
19.
Al-Banna, Nadia, et al.. (2013). Leukocyte-endothelial interactions within the ocular microcirculation in inflammation and infection. Clinical Hemorheology and Microcirculation. 55(4). 423–443. 8 indexed citations
20.
Toguri, James Thomas, Christine Lehmann, Robert B. Laprairie, et al.. (2013). Anti‐inflammatory effects of cannabinoid CB2 receptor activation in endotoxin‐induced uveitis. British Journal of Pharmacology. 171(6). 1448–1461. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon N. Pettit Breakdown of academic impact, for papers by Han Na Park Breakdown of academic impact, for papers by Rachel Y. Gao Breakdown of academic impact, for papers by Antonio Munafò Breakdown of academic impact, for papers by Ernst Agneter Breakdown of academic impact, for papers by Alan J. Tuchman Breakdown of academic impact, for papers by Carlos Eduardo Silvado Breakdown of academic impact, for papers by Kenneth Clark Breakdown of academic impact, for papers by Andrew Winterborn Breakdown of academic impact, for papers by E Molina
Rankless by CCL
2026